Brussels, Belgium

William R Van Dorsser



Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 64(Granted Patents)


Location History:

  • Brussels, BE (1982 - 1987)
  • Court-St-Etienne, BE (1985 - 1988)

Company Filing History:


Years Active: 1982-1988

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of William R Van Dorsser

Introduction

William R Van Dorsser is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on chemical compounds that have various applications in medicine.

Latest Patents

Among his latest patents is a compound described as .alpha..sub.2 -blocking derivatives of imidazole. This compound features a specific formula where X.sup.1, X.sup.2, Y.sup.1, and Y.sup.2 can be hydrogen, halogens such as fluoro, chloro, or bromo, and various alkyl or alkoxy groups. Another significant patent involves derivatives of glycinamide, which includes a glycinamide derivative of a general formula that encompasses a range of alkyl, alkenyl, and acyl groups, showcasing the versatility of his inventions.

Career Highlights

Throughout his career, William R Van Dorsser has worked with reputable companies such as Continental Pharma Incorporated and G.D. Searle & Company. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

William has collaborated with notable individuals in his field, including Claude L Gillet and Joseph L Roba. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

William R Van Dorsser's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to inspire advancements in medical chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…